Patents by Inventor James P. Porter

James P. Porter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9563987
    Abstract: A diagnostic display device is coupled to a vehicle data bus and receives vehicle identification information which is used to identify one or more expected onboard systems installed on the vehicle. Expected systems are queried to determine that they are present and operating properly. Presence and operation status information are stored and/or presented to a user to facilitate automated vehicle system inspection.
    Type: Grant
    Filed: September 30, 2013
    Date of Patent: February 7, 2017
    Assignee: BENDIX COMMERCIAL VEHICLE SYSTEMS LLC
    Inventors: Timothy J. Frashure, Richard J. Conklin, James P. Porter
  • Publication number: 20150094905
    Abstract: A diagnostic display device is coupled to a vehicle data bus and receives vehicle identification information which is used to identify one or more expected onboard systems installed on the vehicle. Expected systems are queried to determine that they are present and operating properly. Presence and operation status information are stored and/or presented to a user to facilitate automated vehicle system inspection.
    Type: Application
    Filed: September 30, 2013
    Publication date: April 2, 2015
    Applicant: BENDIX COMMERCIAL VEHICLE SYSTEMS LLC
    Inventors: Timothy J. Frashure, Richard J. Conklin, James P. Porter
  • Patent number: 7870535
    Abstract: A system and a method for developing Internet-hosted business applications composed of web services and software for use in such environments where applications and application components interoperate to perform requested business functions. The system and method of the present invention utilize a software development application services provider module (DASP), an Instantiatior module, a Builder module, an Applications Service Provider (ASP) Infrastructure Platform (AIP) module, and a hosted production environment module. The system and method of the present invention seeks to maximize the use of prior work to eliminate repetition and reduce development cost and development time. With each new project the library and experience increases.
    Type: Grant
    Filed: February 21, 2002
    Date of Patent: January 11, 2011
    Assignee: Accenture Global Services GmbH
    Inventors: Donald J. Rippert, Jr., James P. Porter, Michael G. Condon
  • Patent number: 7691384
    Abstract: The present invention includes a method to detect IgE using a human Fc epsilon receptor (Fc68 R) to detect IgE antibodies in a biological sample from a cat, a dog, or a horse. The present invention also relates to kits to perform such methods.
    Type: Grant
    Filed: March 8, 2007
    Date of Patent: April 6, 2010
    Assignee: Heska Corporation
    Inventors: Glenn R. Frank, James P. Porter, Keith E. Rushlow, Donald L. Wassom
  • Patent number: 7195767
    Abstract: The present invention includes a method to detect IgE using a human Fc epsilon receptor (Fc?R) to detect IgE antibodies in a biological sample from a cat, a dog, or a horse. The present invention also relates to kits to perform such methods.
    Type: Grant
    Filed: December 16, 2005
    Date of Patent: March 27, 2007
    Assignee: Heska Corporation
    Inventors: Glenn R. Frank, James P. Porter, Keith E. Rushlow, Donald L. Wassom
  • Publication number: 20040214209
    Abstract: The present invention includes a method to detect IgE using a human Fc epsilon receptor (Fc&egr;R) to detect IgE antibodies in a biological sample from a cat dog, horse or mouse. The present invention also relates to kits to perform such methods.
    Type: Application
    Filed: January 23, 2004
    Publication date: October 28, 2004
    Inventors: Glenn R. Frank, James P. Porter, Keith E. Rushlow, Donald L. Wassom
  • Publication number: 20040117759
    Abstract: A system and a method for developing Internet-hosted business applications composed of web services and software for use in such environments where applications and application components interoperate to perform requested business functions. The system and method of the present invention utilize a software development application services provider module (DASP), an Instantiatior module, a Builder module, an Applications Service Provider (ASP) Infrastructure Platform (AIP) module, and a hosted production environment module. The system and method of the present invention seeks to maximize the use of prior work to eliminate repetition and reduce development cost and development time. With each new project the library and experience increases.
    Type: Application
    Filed: February 4, 2004
    Publication date: June 17, 2004
    Inventors: Donald J Rippert, James P Porter, Michael G Condon
  • Patent number: 6682894
    Abstract: The present invention includes a method to detect IgE using a human Fc epsilon receptor (Fc&egr;R) to detect IgE antibodies in a biological sample from a cat, a dog, or a horse. The present invention also relates to kits to perform such methods.
    Type: Grant
    Filed: August 30, 2001
    Date of Patent: January 27, 2004
    Assignee: Heska Corporation
    Inventors: Glenn R. Frank, James P. Porter, Keith E. Rushlow, Donald L. Wassom
  • Publication number: 20030170749
    Abstract: The present invention includes a method to detect D. immitis infection in a host animal using a D. immitis Di33 protein to detect anti-D. immitis Di33 antibodies in a bodily fluid of the animal. Also included is a method to detect D. immitis infection in a host animal using a D. immitis anti-Di33 protein to detect Di33 proteins in a bodily fluid of the animal. The present invention also relates to D. immitis detection kits that include either a Di33 protein or an anti-Di33 antibody; such kits also include a composition to detect an immunocomplex between the anti-Di33 antibody and D. immitis Di33 protein. The present invention also includes Di33 proteins, nucleic acid molecules encoding such proteins, as well as recombinant molecules and recombinant cells comprising such nucleic acid molecules, and anti-Di33 antibodies. Also included are methods to produce such proteins, nucleic acid molecules and antibodies.
    Type: Application
    Filed: May 17, 2002
    Publication date: September 11, 2003
    Inventors: Robert B. Grieve, Glenn R. Frank, Roy R. Mondesire, James P. Porter, Nancy Wisnewski
  • Patent number: 6391569
    Abstract: The present invention includes a method to detect D. immitis infection in a host animal using a D. immitis Di33 protein to detect anti-D. immitis Di33 antibodies in a bodily fluid of the animal. Also included is a method to detect D. immitis infection in a host animal using a D. immitis anti-Di33 protein to detect Di33 proteins in a bodily fluid of the animal. The present invention also relates to D. immitis detection kits that include either a Di33 protein or an anti-Di33 antibody; such kits also include a composition to detect an immunocomplex between the anti-Di33 antibody and D. immitis Di33 protein. The present invention also includes Di33 proteins, nucleic acid molecules encoding such proteins, as well as recombinant molecules and recombinant cells comprising such nucleic acid molecules, and anti-Di33 antibodies. Also included are methods to produce such proteins, nucleic acid molecules and antibodies.
    Type: Grant
    Filed: September 18, 1996
    Date of Patent: May 21, 2002
    Assignee: Heska Corporation
    Inventors: Robert B. Grieve, Glenn R. Frank, Roy R. Mondesire, James P. Porter, Nancy Wisnewski
  • Publication number: 20020034771
    Abstract: The present invention includes a method to detect IgE using a human Fc epsilon receptor (Fc&egr;R) to detect IgE antibodies in a biological sample from a cat, a dog, or a horse. The present invention also relates to kits to perform such methods.
    Type: Application
    Filed: August 30, 2001
    Publication date: March 21, 2002
    Inventors: Glenn R. Frank, James P. Porter, Keith E. Rushlow, Donald L. Wassom
  • Patent number: 6309832
    Abstract: The present invention includes a method to detect IgE using a human Fc epsilon receptor (Fc&egr;R) to detect IgE antibodies in a biological sample from a cat, a dog, or a horse. The present invention also relates to kits to perform such methods.
    Type: Grant
    Filed: March 31, 1999
    Date of Patent: October 30, 2001
    Assignee: Heska Corporation
    Inventors: Glenn R. Frank, James P. Porter, Keith E. Rushlow, Donald L. Wassom
  • Patent number: 6284881
    Abstract: The present invention relates to feline Fc epsilon receptor alpha chain nucleic acid molecules, compositions comprising such nucleic acid molecules, and methods to use such nucleic acid molecules to produce feline Fc epsilon receptor alpha chain proteins.
    Type: Grant
    Filed: February 29, 2000
    Date of Patent: September 4, 2001
    Assignee: Heska Corporation
    Inventors: Glenn R. Frank, James P. Porter, Keith E. Rushlow, Donald L. Wassom, Eric R. Weber
  • Patent number: 6103494
    Abstract: The present invention relates to feline Fc epsilon receptor alpha chain nucleic acid molecules, proteins encoded by such nucleic acid molecules, antibodies raised against such proteins, and inhibitors of such proteins. The present invention also includes methods to detect IgE using such proteins and antibodies. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to mediate Fc epsilon receptor-mediated biological responses.
    Type: Grant
    Filed: January 9, 1998
    Date of Patent: August 15, 2000
    Assignee: Heska Corporation
    Inventors: Glenn R. Frank, James P. Porter, Keith E. Rushlow, Donald L. Wassom, Eric R. Weber
  • Patent number: 5958880
    Abstract: The present invention relates to feline Fc epsilon receptor alpha chain nucleic acid molecules, proteins encoded by such nucleic acid molecules, antibodies raised against such proteins, and inhibitors of such proteins. The present invention also includes methods to detect IgE using such proteins and antibodies. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to mediate Fc epsilon receptor-mediated biological responses.
    Type: Grant
    Filed: December 19, 1996
    Date of Patent: September 28, 1999
    Assignee: Heska Corporation
    Inventors: Glenn R. Frank, James P. Porter, Keith E. Rushlow, Donald L. Wassom, Eric R. Weber
  • Patent number: 5945294
    Abstract: The present invention includes a method to detect IgE using a human Fc epsilon receptor (Fc.sub..epsilon. R) to detect IgE antibodies in a biological sample from a cat, a dog, or a horse. The present invention also relates to kits to perform such methods.
    Type: Grant
    Filed: November 26, 1996
    Date of Patent: August 31, 1999
    Assignee: Heska Corporation
    Inventors: Glenn R. Frank, James P. Porter, Keith E. Rushlow, Donald L. Wassom
  • Patent number: 4806467
    Abstract: The present invention relates to a method of detecting either antibody or antigen in the serum of horses infected with equine infectious anemia using a competitive enzyme-linked immunoabsorbent assay technique and reagents useful in such an assay. The competitive enzyme-linked immunoabsorbent assay incorporates a purified virus antigen conjugate and a monoclonal antibody specific for the virus antigen as both the reacting and competing components. Alternatively, the competitive enzyme-linked immunoabsorbent assay incorporates a purified virus antigen and a monoclonal antibody conjugate specific for the viral antigen as both reacting and competing components. This invention also relates to detecting antigen and antibody found in other retrovirus infections such as Acquired Immunodeficiency Syndrome in humans.
    Type: Grant
    Filed: October 21, 1985
    Date of Patent: February 21, 1989
    Assignee: Fermenta Animal Health Company
    Inventors: James P. Porter, Tatsuo Matsushita, Lyndal K. Hesterberg